ArticleTraffic (Copenhagen, Denmark)2026
Syntaxin 12 Sustains Endosomal-Lysosomal Homeostasis and Survival in Glioblastoma Stem-Like Cells.
Article in Traffic (Copenhagen, Denmark), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Glioblastoma cells display a striking vulnerability to disruptions in late endosome-lysosome trafficking, a dependency that we exploited through a targeted siRNA screen in patient-derived cells with stem-like properties (GSCs). This screen identified Syntaxin 12 (STX12) as a critical determinant of GSC survival. Originally characterized as a recycling endosome t-SNARE, STX12 regulates tubular recycling and retrograde transport, yet its broader implications for lysosomal homeostasis remain poorly understood. Functional characterization revealed that STX12 is required to maintain lysosomal organization in GSCs, consistent with its known roles as an endosomal t-SNARE. Loss of STX12 altered dynamic processes that support GSC fitness, culminating in controlling life-and-death decisions. Because lysosomal function is deeply connected with the autophagic pathway, we next explored whether STX12 contributes to this adaptive program. STX12 silencing produced signatures consistent with impaired endo-lysosomal progression and disrupted mechanistic target of rapamycin (mTOR)/lysosome communication. This work further identifies a previously unrecognized role for STX12 in the adaptive trafficking network that supports glioblastoma cell survival, revealing a potential SNARE-centered vulnerability for therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.